Efficacy and safety of capecitabine as maintenance therapy after capecitabine-based combination chemotherapy for patients with advanced esophagogastric junction adenocarcinoma

Lu B.; Bao L. -B.; Sun Z.; Hua Z. -L.; Wang X.; Qu C. -P.

首页> 外文期刊>European review for medical and pharmacological sciences. >Efficacy and safety of capecitabine as maintenance therapy after capecitabine-based combination chemotherapy for patients with advanced esophagogastric junction adenocarcinoma

【24h】

Efficacy and safety of capecitabine as maintenance therapy after capecitabine-based combination chemotherapy for patients with advanced esophagogastric junction adenocarcinoma

机译：卡培他滨联合化疗治疗晚期食管胃交界腺癌的疗效及安全性

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

OBJECTIVE: The aim of the present study was to investigate the efficacy and safety of single-agent capecitabine therapy after capecitabine-based combination chemotherapy for patients with advanced adenocarcinoma of the esophagogastric junction (EGJ).

机译：目的：本研究的目的是探讨以卡培他滨为基础的联合化疗后单药卡培他滨治疗晚期食管胃交界性腺癌（EGJ）的疗效和安全性。

著录项

来源
《European review for medical and pharmacological sciences.》 |2015年第19期|共8页
作者
Lu B.; Bao L. -B.; Sun Z.; Hua Z. -L.; Wang X.; Qu C. -P.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
Advanced esophagogastric junction (EGJ) adenocarcinoma; Capecitabine; Maintenance therapy;

机译：食管胃晚期腺癌;卡培他滨;维持治疗;

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of capecitabine as maintenance therapy after capecitabine-based combination chemotherapy for patients with advanced esophagogastric junction adenocarcinoma [J] . Lu B., Bao L. -B., Sun Z., European review for medical and pharmacological sciences. . 2015,第19期

机译：卡培他滨联合化疗治疗晚期食管胃交界腺癌的疗效及安全性
2. Efficacy and safety of capecitabine as maintenance treatment after first-line chemotherapy using oxaliplatin and capecitabine in advanced gastric adenocarcinoma patients: a prospective observation. [J] . QiuM.Z., WeiX.L., ZhangD.S., Tumour biology : . 2014,第5期

机译：奥沙利铂和卡培他滨一线化疗后卡培他滨在晚期胃腺癌患者中作为维持治疗的疗效和安全性：前瞻性观察。
3. Hormonal therapy might be a better choice as maintenance treatment than capecitabine after response to first-line capecitabine-based combination chemotherapy for patients with hormone receptor-positive and HER2-negative, metastatic breast cancer [J] . Xue-Lian Chen, Feng Du, Ruo-Xi Hong, Chinese journal of cancer . 2016,第1期

机译：对于激素受体阳性和HER2阴性，转移性乳腺癌的患者，在一线基于卡培他滨的联合化疗后，激素治疗可能是比卡培他滨更好的维持治疗方法
4. Efficacy of combination chemotherapy with docetaxel and irinotecan as first- or second-line treatment for advanced gastric cancer [C] . K. Sugiyama, A. Ishikawa, T. Watanabe International Gastric Cancer Congress . 2009

机译：组合化疗与多西紫杉醇和伊替康的疗效，作为晚期胃癌的第一或二线治疗
5. Mechanism of action of, and combination chemotherapy with isoprenoids perillyl alcohol, farnesol, and geraniol in in vitro and in vivo models of human pancreatic adenocarcinoma. [D] . Wiseman, Dean Allen. 2004

机译：异戊二烯类紫苏醇，法尼醇和香叶醇在人胰腺癌的体内和体外模型中的作用机理以及联合化疗的作用。
6. Hormonal therapy might be a better choice as maintenance treatment than capecitabine after response to first-line capecitabine-based combination chemotherapy for patients with hormone receptor-positive and HER2-negative metastatic breast cancer [O] . Xue-Lian Chen, Feng Du, Ruo-Xi Hong, 2016

机译：对于激素受体阳性和HER2阴性转移性乳腺癌的患者在一线基于卡培他滨的联合化疗后激素治疗可能是比卡培他滨更好的维持治疗方法
7. Hormonal therapy might be a better choice as maintenance treatment than capecitabine after response to first-line capecitabine-based combination chemotherapy for patients with hormone receptor-positive and HER2-negative, metastatic breast cancer [O] . Xue-Lian Chen, Feng Du, Ruo-Xi Hong, 2016

机译：对于激素受体阳性和HER2阴性，转移性乳腺癌的患者，在一线基于卡培他滨的联合化疗后，激素治疗可能是比卡培他滨更好的维持治疗方法

Efficacy and safety of capecitabine as maintenance therapy after capecitabine-based combination chemotherapy for patients with advanced esophagogastric junction adenocarcinoma

摘要

著录项

相似文献

相关主题

期刊订阅